Search
HomeBusiness

Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.

NY Times
NY Times

The drug, Aduhelm, has been mired in controversy since it was in approved in the United States in June.  » mehr lesen

NY Times
NY Times
Previous article
Staples Center in Los Angeles will be renamed Crypto.com Arena.
Next article
Peloton and Zoom were two of the hot stocks of the pandemic. Now what?

Similar Articles

Tottenham Hotspur Owner Joe Lewis Is Charged in U.S. With Insider Trading

Business NY Times -
Federal prosecutors in Manhattan accused the British billionaire of illegally funneling nonpublic information to associates to trade on.  » mehr lesen

How Travelers Can Navigate Flight Cancellations and Delays

Business NY Times -
Advocating for yourself after an airline delay or cancellation can be challenging and confusing. Here’s how to best achieve the result you want —...

Most Popular

Copyright @ Home Business Factor | Created with ♥ in North Carolina